Steven M. Foster - 14 Nov 2025 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Reporting relationship: CEO and President, Director
Issuer ticker: TNON
Reported as of: 14 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Nov 2025, 20:42:50 UTC
Prior SEC filing: 15 Oct 2025
Next SEC filing: 05 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Steven Foster

Key filing fact

Steven M. Foster filed Form 4 for Tenon Medical, Inc. (TNON) on 18 Nov 2025.

Key facts

This page summarizes Steven M. Foster's Form 4 filing for Tenon Medical, Inc. (TNON).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 18 Nov 2025, 20:42.

Change

Previous filing in this sequence was filed on 15 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001897435 Primary reporting owner

FOSTER STEVEN M

Relationship: CEO and President, Director
Address: 104 COOPER CT., LOS GATOS
Signature: /s/ Steven Foster
Signature date: 18 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TNON transaction

Common stock

Purchase

Transaction value
Shares: +19,455
Change %: +568%
Price
Shares after: 22,878
Date: 14 Nov 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TNON transaction Derivative

Common Stock Purchase Warrant

Purchase

Transaction value
Shares: +19,455
Change %
Price
Shares after: 19,455
Date: 14 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 19,455
Exercise price: $1.16
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On November 10, 2025, the Issuer entered into a Securities Purchase Agreement for an at-the-market private investment in public equity transaction, in which the reporting person purchased 19,455 shares of common stock of the Issuer and warrants to purchase up to 19,455 shares of common stock of the Issuer. The purchase price for each share of common stock and accompanying warrant was $1.285. The offering closed on November 14, 2025.